Oramed Pharmaceuticals Stock Market Value
| ORMP Stock | USD 2.46 0.01 0.40% |
| Symbol | Oramed |
Oramed Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oramed Pharmaceuticals. If investors know Oramed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oramed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.51 | Quarterly Revenue Growth (1.00) | Return On Assets (0.04) | Return On Equity 0.0289 |
The market value of Oramed Pharmaceuticals is measured differently than its book value, which is the value of Oramed that is recorded on the company's balance sheet. Investors also form their own opinion of Oramed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Oramed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oramed Pharmaceuticals' market value can be influenced by many factors that don't directly affect Oramed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oramed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oramed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oramed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oramed Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oramed Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oramed Pharmaceuticals.
| 11/04/2024 |
| 12/04/2024 |
If you would invest 0.00 in Oramed Pharmaceuticals on November 4, 2024 and sell it all today you would earn a total of 0.00 from holding Oramed Pharmaceuticals or generate 0.0% return on investment in Oramed Pharmaceuticals over 30 days. Oramed Pharmaceuticals is related to or competes with Protalix Biotherapeutics, Corvus Pharmaceuticals, Aldeyra, Checkpoint Therapeutics, BioLineRx, Ardelyx, and Lexicon Pharmaceuticals. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of dia... More
Oramed Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oramed Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oramed Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.38 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 11.99 | |||
| Value At Risk | (3.33) | |||
| Potential Upside | 4.22 |
Oramed Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oramed Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oramed Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Oramed Pharmaceuticals historical prices to predict the future Oramed Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0298 | |||
| Jensen Alpha | 0.0582 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 2.39 |
Oramed Pharmaceuticals Backtested Returns
Currently, Oramed Pharmaceuticals is relatively risky. Oramed Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.0534, which implies the firm had a 0.0534% return per unit of risk over the last 3 months. We have found thirty technical indicators for Oramed Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check Oramed Pharmaceuticals' Risk Adjusted Performance of 0.0298, coefficient of variation of 3314.2, and Semi Deviation of 2.18 to confirm if the risk estimate we provide is consistent with the expected return of 0.13%. Oramed Pharmaceuticals has a performance score of 4 on a scale of 0 to 100. The company holds a Beta of 0.0255, which implies not very significant fluctuations relative to the market. As returns on the market increase, Oramed Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Oramed Pharmaceuticals is expected to be smaller as well. Oramed Pharmaceuticals right now holds a risk of 2.35%. Please check Oramed Pharmaceuticals standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to decide if Oramed Pharmaceuticals will be following its historical price patterns.
Auto-correlation | -0.69 |
Very good reverse predictability
Oramed Pharmaceuticals has very good reverse predictability. Overlapping area represents the amount of predictability between Oramed Pharmaceuticals time series from 4th of November 2024 to 19th of November 2024 and 19th of November 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oramed Pharmaceuticals price movement. The serial correlation of -0.69 indicates that around 69.0% of current Oramed Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.69 | |
| Spearman Rank Test | -0.66 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Oramed Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Oramed Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oramed Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Oramed Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Oramed Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Oramed Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oramed Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oramed Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oramed Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Oramed Pharmaceuticals Lagged Returns
When evaluating Oramed Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oramed Pharmaceuticals stock have on its future price. Oramed Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oramed Pharmaceuticals autocorrelation shows the relationship between Oramed Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Oramed Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Oramed Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oramed Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Oramed Stock
| 0.36 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.35 | VRNA | Verona Pharma PLC | PairCorr |
| 0.34 | ELDN | Eledon Pharmaceuticals | PairCorr |
| 0.32 | ETON | Eton Pharmaceuticals Downward Rally | PairCorr |
The ability to find closely correlated positions to Oramed Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oramed Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oramed Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oramed Pharmaceuticals to buy it.
The correlation of Oramed Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oramed Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oramed Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oramed Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Oramed Stock Analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.